Multiple Sclerosis (MS) is a neurological condition which affects around 100,000 people in the UK.
The condition causes a person’s immune system to attack the nerve fibres and their lining in the brain and spinal cord resulting in messages from the central nervous system being delayed or distorted. This can lead to a range of symptoms such as issues with vision, mobility and cognitive problems such as memory and thinking.
Sheffield Teaching Hospitals are currently part of a major international clinical trial that is trialing a new ground breaking therapy for patients with relapsing/remitting MS.
The treatment, which is called autologous haematopoietic stem cell transplantation (AHSCT) destroys the faulty immune system using chemotherapy before reintroducing the patient’s own bone marrow stem cells that have not yet developed the MS trigger.
Professors at the Royal Hallamshire Hospital have treated around 20 patients with this new approach and have seen some staggering results as featured on BBC Panorama on Monday 18th January 2016.
Sheffield Hospitals Charity are proud to support this research project carried out in Sheffield.
Click here to find out more about AHSCT and the clinical trial.